9717 Key West Avenue
Suite 100
Rockville, MD 20850
United States
240 813 1260
https://www.opgen.com
Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno:
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Dr. Oliver Schacht Ph.D. | Executive VP of Corporate Development | 353,48k | N/D | 1971 |
Mr. David Elliot Lazar | CEO & Chairman | N/D | N/D | 1991 |
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.
L'ISS Governance QualityScore di OpGen, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.